Not applicableStudy completedNCT02376296What this trial is testingObservational Study of Docetaxel Exposure in Metastatic Prostate Cancer PatientsWho this might be right forProstate Cancer Saladax Biomedical, Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT01352208What this trial is testingPhase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) PatientsWho this might be right forCastrate Resistant Prostate Cancer Astellas Pharma Inc 13
Testing effectiveness (Phase 2)Study completedNCT03101046What this trial is testingTreatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells KineticWho this might be right forProstate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT01393730What this trial is testingAbiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate CancerWho this might be right forProstate Cancer Mary-Ellen Taplin, MD 40
Large-scale testing (Phase 3)Ended earlyNCT02438007What this trial is testingGaleterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCWho this might be right forProstate Cancer LTN PHARMACEUTICALS, INC. 953
Early research (Phase 1)WithdrawnNCT02864784What this trial is testingInvestigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPCWho this might be right forCastrate Resistant Prostate Cancer With Bone Metastasis Amorphical Ltd.
Not applicableLooking for participantsNCT06720532What this trial is testingKidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-TrialWho this might be right forKidney DiseaseRadiation NephropathyMetastatic Castrate Resistant Prostate Cancer (mCRPC) Hannah Schaefer 100
Early research (Phase 1)Study completedNCT03751436What this trial is testingEnzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forCastration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+6 more Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT01385228What this trial is testingPazopanib, Docetaxel, Prednisone ProstateWho this might be right forProstate Cancer Daniel George, MD 36
Large-scale testing (Phase 3)Study completedNCT05547386What this trial is testing68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8 Mayo Clinic 163
Early research (Phase 1)Study completedNCT03024216What this trial is testingClinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate CancerWho this might be right forProstate Cancer Metastatic University of Hawaii 37
Testing effectiveness (Phase 2)Looking for participantsNCT06594926What this trial is testingWorking Out M0 Bipolar Androgen TherapyWho this might be right forProstate Cancer Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Not applicableStudy completedNCT04995614What this trial is testingHealth-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223Who this might be right forCastrate Resistant Prostate CancerBone Metastases Radboud University Medical Center 122
Testing effectiveness (Phase 2)Ended earlyNCT02607228What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate CancerWho this might be right forMetastatic Castrate-Resistant Prostate Cancer Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT02105675What this trial is testingPhase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerWho this might be right forProstate CancerProstate Cancer Metastatic SOTIO a.s. 60
Testing effectiveness (Phase 2)Ended earlyNCT03514836What this trial is testingA Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate CancerWho this might be right forCastration-resistant Prostate Cancer SOTIO a.s. 5
Testing effectiveness (Phase 2)Study completedNCT03899467What this trial is testingThe Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPCWho this might be right forMetastatic Castrate Resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Suzhou Kintor Pharmaceutical Inc, 61
Testing effectiveness (Phase 2)Study completedNCT01683994What this trial is testingCabozantinib Plus Docetaxel and Prednisone for Advanced Prostate CancerWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 49
Large-scale testing (Phase 3)Looking for participantsNCT06629779What this trial is testingLearn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Who this might be right forMetastatic Castration-Resistant Prostate Cancer Pfizer 900
Testing effectiveness (Phase 2)Ended earlyNCT03729596What this trial is testingMGC018 With or Without MGA012 in Advanced Solid TumorsWho this might be right forSquamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more MacroGenics 143